Amphastar Pharmaceuticals Inc vs Kohl's Corporation — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Kohl's Corporation trades at $18.7 (market cap $2.10B). The key difference: Kohl's Corporation is far larger — about 2.4× Amphastar Pharmaceuticals Inc's market cap, and Kohl's Corporation pays a 2.7% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | KSS | |
|---|---|---|
Market Cap | $868.62M | $2.10B |
Sector | Health | Consumer Cyclical |
52-Week High | $30.81 | $24.71 |
52-Week Low | $16.87 | $11.72 |
Enterprise Value | $1.27B | $8.20B |
Dividend Yield | — | 2.7% |
Trailing returns across standard periods
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →Kohl's operates 1,165 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also operates a large digital sales business. Women's apparel is Kohl's largest category, having generated 27% of its 2021 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
Read more on KSS →